{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T04:10:59Z","timestamp":1751515859302,"version":"3.41.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"crossref","award":["SZSM202111003"],"award-info":[{"award-number":["SZSM202111003"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02658-5","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T16:05:18Z","timestamp":1751472318000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of surgery and survival prediction in patients with bladder neuroendocrine carcinoma: a novel propensity score-matched population-based cohort study"],"prefix":"10.1186","volume":"30","author":[{"given":"Jianyong","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shicong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runhua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"issue":"3","key":"2658_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"2658_CR2","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nrurol.2017.125","volume":"14","author":"M Moschini","year":"2017","unstructured":"Moschini M, D\u2019Andrea D, Korn S, et al. Characteristics and clinical significance of histological variants of bladder cancer. Nat Rev Urol. 2017;14(11):651\u201368. https:\/\/doi.org\/10.1038\/nrurol.2017.125.","journal-title":"Nat Rev Urol"},{"issue":"1","key":"2658_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","volume":"70","author":"PA Humphrey","year":"2016","unstructured":"Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE. The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours. Eur Urol. 2016;70(1):106\u201319. https:\/\/doi.org\/10.1016\/j.eururo.2016.02.028.","journal-title":"Eur Urol"},{"issue":"6","key":"2658_CR4","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.21873\/anticanres.12589","volume":"38","author":"B P\u00f3sfai","year":"2018","unstructured":"P\u00f3sfai B, Kuthi L, Varga L, et al. The colorful palette of neuroendocrine neoplasms in the genitourinary tract. Anticancer Res. 2018;38(6):3243\u201354. https:\/\/doi.org\/10.21873\/anticanres.12589.","journal-title":"Anticancer Res"},{"issue":"3","key":"2658_CR5","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.juro.2009.11.018","volume":"183","author":"M Ploeg","year":"2010","unstructured":"Ploeg M, Aben KK, Hulsbergen-van de Kaa CA, Schoenberg MP, Witjes JA, Kiemeney LA. Clinical epidemiology of nonurothelial bladder cancer: analysis of the Netherlands Cancer Registry. J Urol. 2010;183(3):915\u201320. https:\/\/doi.org\/10.1016\/j.juro.2009.11.018.","journal-title":"J Urol"},{"issue":"6","key":"2658_CR6","doi-asserted-by":"publisher","first-page":"E30","DOI":"10.1684\/bdc.2009.0883","volume":"96","author":"N Ismaili","year":"2009","unstructured":"Ismaili N, Arifi S, Flechon A, et al. Small cell cancer of the bladder: pathology, diagnosis, treatment and prognosis. Bull Cancer. 2009;96(6):E30-44. https:\/\/doi.org\/10.1684\/bdc.2009.0883.","journal-title":"Bull Cancer"},{"issue":"2","key":"2658_CR7","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/COC.0b013e3182438c71","volume":"36","author":"D Schreiber","year":"2013","unstructured":"Schreiber D, Rineer J, Weiss J, et al. Characterization and outcomes of small cell carcinoma of the bladder using the surveillance, epidemiology, and end results database. Am J Clin Oncol. 2013;36(2):126\u201331. https:\/\/doi.org\/10.1097\/COC.0b013e3182438c71.","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"2658_CR8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.juro.2013.09.009","volume":"191","author":"SG Patel","year":"2014","unstructured":"Patel SG, Stimson CJ, Zaid HB, et al. Locoregional small cell carcinoma of the bladder: clinical characteristics and treatment patterns. J Urol. 2014;191(2):329\u201334. https:\/\/doi.org\/10.1016\/j.juro.2013.09.009.","journal-title":"J Urol"},{"issue":"6","key":"2658_CR9","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.euf.2017.09.001","volume":"4","author":"BW Fischer-Valuck","year":"2018","unstructured":"Fischer-Valuck BW, Rao YJ, Henke LE, et al. Treatment patterns and survival outcomes for patients with small cell carcinoma of the bladder. Eur Urol Focus. 2018;4(6):900\u20136. https:\/\/doi.org\/10.1016\/j.euf.2017.09.001.","journal-title":"Eur Urol Focus"},{"issue":"1","key":"2658_CR10","first-page":"250","volume":"188","author":"F Li","year":"2019","unstructured":"Li F, Thomas LE, Li F. Addressing extreme propensity scores via the overlap weights. Am J Epidemiol. 2019;188(1):250\u20137.","journal-title":"Am J Epidemiol"},{"issue":"521","key":"2658_CR11","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1080\/01621459.2016.1260466","volume":"113","author":"F Li","year":"2018","unstructured":"Li F, Morgan KL, Zaslavsky AM. Balancing covariates via propensity score weighting. J Am Stat Assoc. 2018;113(521):390\u2013400.","journal-title":"J Am Stat Assoc"},{"issue":"23","key":"2658_CR12","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1001\/jama.2020.7819","volume":"323","author":"LE Thomas","year":"2020","unstructured":"Thomas LE, Li F, Pencina MJ. Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial. JAMA. 2020;323(23):2417\u20138. https:\/\/doi.org\/10.1001\/jama.2020.7819.","journal-title":"JAMA"},{"issue":"6","key":"2658_CR13","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/aje\/kwac043","volume":"191","author":"C Cheng","year":"2022","unstructured":"Cheng C, Li F, Thomas LE, Li FF. Addressing extreme propensity scores in estimating counterfactual survival functions via the overlap weights. Am J Epidemiol. 2022;191(6):1140\u201351. https:\/\/doi.org\/10.1093\/aje\/kwac043.","journal-title":"Am J Epidemiol"},{"issue":"12","key":"2658_CR14","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.jval.2019.06.010","volume":"22","author":"T Mlcoch","year":"2019","unstructured":"Mlcoch T, Hrnciarova T, Tuzil J, Zadak J, Marian M, Dolezal T. Propensity score weighting using overlap weights: a new method applied to regorafenib clinical data and a cost-effectiveness analysis. Value Health. 2019;22(12):1370\u20137. https:\/\/doi.org\/10.1016\/j.jval.2019.06.010.","journal-title":"Value Health"},{"key":"2658_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2021.106165","volume":"96","author":"G Mathew","year":"2021","unstructured":"Mathew G, Agha R, Albrecht J, et al. STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Int J Surg (London, England). 2021;96: 106165. https:\/\/doi.org\/10.1016\/j.ijsu.2021.106165.","journal-title":"Int J Surg (London, England)"},{"issue":"6","key":"2658_CR16","doi-asserted-by":"publisher","first-page":"307.e1","DOI":"10.1016\/j.urolonc.2018.02.015","volume":"36","author":"M van de Kamp","year":"2018","unstructured":"van de Kamp M, Meijer R, Pos F, et al. Intravesical recurrence after bladder sparing treatment of small cell carcinoma of the bladder: characteristics, treatment, and outcome. Urol Oncol. 2018;36(6):307.e1-307.e8. https:\/\/doi.org\/10.1016\/j.urolonc.2018.02.015.","journal-title":"Urol Oncol"},{"key":"2658_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13154349","author":"F Claps","year":"2024","unstructured":"Claps F, Biasatti A, Di Gianfrancesco L, et al. The prognostic significance of histological subtypes in patients with muscle-invasive bladder cancer: an overview of the current literature. J Clin Med. 2024. https:\/\/doi.org\/10.3390\/jcm13154349.","journal-title":"J Clin Med"},{"issue":"2","key":"2658_CR18","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/bju.15984","volume":"132","author":"F Claps","year":"2023","unstructured":"Claps F, van de Kamp MW, Mayr R, et al. Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy. BJU Int. 2023;132(2):170\u201380. https:\/\/doi.org\/10.1111\/bju.15984.","journal-title":"BJU Int"},{"issue":"6","key":"2658_CR19","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/iju.12729","volume":"22","author":"D Kaushik","year":"2015","unstructured":"Kaushik D, Frank I, Boorjian SA, et al. Long-term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder. Int J Urol. 2015;22(6):549\u201354. https:\/\/doi.org\/10.1111\/iju.12729.","journal-title":"Int J Urol"},{"issue":"1","key":"2658_CR20","doi-asserted-by":"publisher","first-page":"5043","DOI":"10.4081\/rt.2014.5043","volume":"6","author":"VR Bhatt","year":"2014","unstructured":"Bhatt VR, Loberiza FR Jr, Tandra P, Krishnamurthy J, Shrestha R, Wang J. Risk factors, therapy and survival outcomes of small cell and large cell neuroendocrine carcinoma of urinary bladder. Rare Tumors. 2014;6(1):5043. https:\/\/doi.org\/10.4081\/rt.2014.5043.","journal-title":"Rare Tumors."},{"issue":"2","key":"2658_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.eururo.2012.04.020","volume":"64","author":"SP Lynch","year":"2013","unstructured":"Lynch SP, Shen Y, Kamat A, et al. Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center. Eur Urol. 2013;64(2):307\u201313. https:\/\/doi.org\/10.1016\/j.eururo.2012.04.020.","journal-title":"Eur Urol"},{"issue":"4","key":"2658_CR22","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1097\/JU.0000000000001855","volume":"206","author":"NH Chakiryan","year":"2021","unstructured":"Chakiryan NH, Jiang DD, Gillis KA, et al. Pathological downstaging and survival outcomes associated with neoadjuvant chemotherapy for variant histology muscle invasive bladder cancer. J Urol. 2021;206(4):924\u201332. https:\/\/doi.org\/10.1097\/JU.0000000000001855.","journal-title":"J Urol"},{"issue":"4","key":"2658_CR23","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.euf.2020.04.011","volume":"6","author":"S Daneshmand","year":"2020","unstructured":"Daneshmand S, Nazemi A. Neoadjuvant chemotherapy in variant histology bladder cancer: current evidence. Eur Urol Focus. 2020;6(4):639\u201341. https:\/\/doi.org\/10.1016\/j.euf.2020.04.011.","journal-title":"Eur Urol Focus"},{"issue":"22","key":"2658_CR24","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1002\/cncr.30907","volume":"123","author":"MW Vetterlein","year":"2017","unstructured":"Vetterlein MW, Wankowicz SAM, Seisen T, et al. Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology. Cancer. 2017;123(22):4346\u201355. https:\/\/doi.org\/10.1002\/cncr.30907.","journal-title":"Cancer"},{"key":"2658_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.907454","volume":"12","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Xiao Y, Hu S, Wang Z, Zhu Z. Neoadjuvant and adjuvant chemotherapy for variant histology bladder cancers: a systematic review and meta-analysis. Front Oncol. 2022;12: 907454. https:\/\/doi.org\/10.3389\/fonc.2022.907454.","journal-title":"Front Oncol"},{"issue":"4","key":"2658_CR26","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.eururo.2018.11.052","volume":"75","author":"M Abufaraj","year":"2019","unstructured":"Abufaraj M, Foerster B, Schernhammer E, et al. Micropapillary urothelial carcinoma of the bladder: a systematic review and meta-analysis of disease characteristics and treatment outcomes. Eur Urol. 2019;75(4):649\u201358. https:\/\/doi.org\/10.1016\/j.eururo.2018.11.052.","journal-title":"Eur Urol"},{"issue":"6","key":"2658_CR27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.urolonc.2016.12.006","volume":"35","author":"M Moschini","year":"2017","unstructured":"Moschini M, Dell\u2019Oglio P, Luciano R, et al. Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy. Urol Oncol Semin Orig Investig. 2017;35(6):335\u201341. https:\/\/doi.org\/10.1016\/j.urolonc.2016.12.006.","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"1","key":"2658_CR28","doi-asserted-by":"publisher","first-page":"21.e1","DOI":"10.1016\/j.urolonc.2014.10.013","volume":"33","author":"A Soave","year":"2015","unstructured":"Soave A, Schmidt S, Dahlem R, et al. Does the extent of variant histology affect oncological outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy? Urol Oncol. 2015;33(1):21.e1-21.e9. https:\/\/doi.org\/10.1016\/j.urolonc.2014.10.013.","journal-title":"Urol Oncol"},{"issue":"2","key":"2658_CR29","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ejso.2020.05.006","volume":"47","author":"M Deuker","year":"2021","unstructured":"Deuker M, Franziska Stolzenbach L, Rosiello G, et al. Radical cystectomy improves survival in patients with stage T1 squamous cell carcinoma and neuroendocrine carcinoma of the urinary bladder. Eur J Surg Oncol. 2021;47(2):463\u20139. https:\/\/doi.org\/10.1016\/j.ejso.2020.05.006.","journal-title":"Eur J Surg Oncol"},{"key":"2658_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2022.02.004","author":"F Dursun","year":"2022","unstructured":"Dursun F, Elshabrawy A, Wang H, et al. Histological variants of non-muscle invasive bladder cancer: survival outcomes of radical cystectomy vs. bladder preservation therapy. Urol Oncol. 2022. https:\/\/doi.org\/10.1016\/j.urolonc.2022.02.004.","journal-title":"Urol Oncol"},{"key":"2658_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2019.11.014","author":"M Sroussi","year":"2020","unstructured":"Sroussi M, Elaidi R, Fl\u00e9chon A, et al. Neuroendocrine carcinoma of the urinary bladder: a large, retrospective study from the French genito-urinary tumor group. Clin Genitourin Cancer. 2020. https:\/\/doi.org\/10.1016\/j.clgc.2019.11.014.","journal-title":"Clin Genitourin Cancer"},{"key":"2658_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14235740","author":"G Marcq","year":"2022","unstructured":"Marcq G, Afferi L, Neuzillet Y, et al. Oncological outcomes for patients harboring positive surgical margins following radical cystectomy for muscle-invasive bladder cancer: a retrospective multicentric study on behalf of the YAU urothelial group. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14235740.","journal-title":"Cancers (Basel)."},{"issue":"12","key":"2658_CR33","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1007\/s00345-021-03776-5","volume":"39","author":"F Claps","year":"2021","unstructured":"Claps F, van de Kamp MW, Mayr R, et al. Risk factors associated with positive surgical margins\u2019 location at radical cystectomy and their impact on bladder cancer survival. World J Urol. 2021;39(12):4363\u201371. https:\/\/doi.org\/10.1007\/s00345-021-03776-5.","journal-title":"World J Urol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02658-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02658-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02658-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T16:05:19Z","timestamp":1751472319000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02658-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2658"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02658-5","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"19 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This was a retrospective study, and clinical data were de-identified before analysis; therefore, ethical approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"564"}}